This prospective study quantified age- and sex-related changes in bone marrow osteoblastic progenitor cells in 57 surgical patients. It measures both total nucleated cell yield and CFU-AP prevalence from standardized 2-ml anterior iliac crest aspirates. The central question: does human aging reduce the pool of osteoblastic progenitors available for bone grafting?
Before this paper, the osteogenic potential of bone marrow aspirates was recognized, but no human data existed on how age or sex affected progenitor cell yield. Surgeons were using bone marrow grafts without knowing whether an elderly woman's aspirate contained meaningfully fewer bone-forming cells than a young man's.
This paper is why we think carefully about patient selection and aspirate technique when using bone marrow for grafting. When treating a non-union or augmenting a graft in an older woman, expect significantly fewer osteoblastic progenitors per aspirate compared to a younger patient or a male patient of the same age.
Use standardized small-volume (2-ml) aspirates from multiple sites along the iliac crest rather than a single large-volume pull. Larger volumes dilute the sample with peripheral blood and reduce progenitor density.
The sex-specific divergence in progenitor prevalence with age provides a potential cellular mechanism for why post-menopausal women suffer disproportionate bone loss, connecting this basic science finding directly to clinical osteoporosis pathophysiology.
This prospective study quantified age- and sex-related changes in bone marrow osteoblastic progenitor cells in 57 surgical patients. It measures both total nucleated cell yield and CFU-AP prevalence from standardized 2-ml anterior iliac crest aspirates. The central question: does human aging reduce the pool of osteoblastic progenitors available for bone grafting?
Before this paper, the osteogenic potential of bone marrow aspirates was recognized, but no human data existed on how age or sex affected progenitor cell yield. Surgeons were using bone marrow grafts without knowing whether an elderly woman's aspirate contained meaningfully fewer bone-forming cells than a young man's.
This paper is why we think carefully about patient selection and aspirate technique when using bone marrow for grafting. When treating a non-union or augmenting a graft in an older woman, expect significantly fewer osteoblastic progenitors per aspirate compared to a younger patient or a male patient of the same age.
Use standardized small-volume (2-ml) aspirates from multiple sites along the iliac crest rather than a single large-volume pull. Larger volumes dilute the sample with peripheral blood and reduce progenitor density.
The sex-specific divergence in progenitor prevalence with age provides a potential cellular mechanism for why post-menopausal women suffer disproportionate bone loss, connecting this basic science finding directly to clinical osteoporosis pathophysiology.